| 摘要 |
The preparation and use of 17-L-[(2'-O- ~-D-glucopyranosyl-p-D~glucopyranosyl)-oxy]-cis-9-octadecenoate, Lactonic and Open ring 17-L-[(2'-O-p~D-glucopyranosyl-~-D-glucopyranosyl)-oxy]-cis-9-octadecenoate, Methyl 17-L~[(2'-O-~-D-glucopyranosyl-~-D-glucopyranosyl)-oxy]-cis-9-octadecenoate, Ethyl 17-L-[(2'-O-~-D-glucopyranosyl-~-D-glucopyranosyl)-oxy]-cis-9-octadecenoate, Hexyl 17-L-[(2'-O-~-D-glucopyranosyl-p-D-glucopyranosyl)-oxy]-cis-9~octadecenoate, Ethyl 17-L-[(2'-O-~-D-glucopyranosyl-~-D-glucopy ranosyl)-oxy]~cis-9-octadecenoate-6"-acetate and Ethyl 17-L-[(2'-O-~-D-glucopyranosyl-~-D~gIucopyranosyl)-oxy]-cis-9-octadecenoate-6' ,6"-diacetate sophorolipids as antifungal agents. |
